Participants	NNS	B-NP	O	Other	No	No	Other	Other	###	1	Participants	Participants	NNS	NNS	_	0	root	_	_
and	CC	O	O	Other	No	No	Other	Other	###	2	and	and	CC	CC	_	1	cc	_	_
Study	NN	B-NP	O	Other	No	No	Other	Other	###	3	Study	Study	NN	NN	_	1	conj	_	_
Design	NN	I-NP	O	Other	No	No	Other	Other	###	4	Design	Design	NN	NN	_	1	dep	_	_

We	PRP	B-NP	O	Other	No	No	Other	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
studied	VBD	B-VP	O	Other	No	No	Other	Other	###	2	studied	studied	VBD	VBD	_	0	root	_	_
patients	NNS	B-NP	O	Other	No	No	Other	Other	###	3	patients	patients	NNS	NNS	_	2	dobj	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	4	with	with	IN	IN	_	6	case	_	_
mild	JJ	B-NP	O	Other	No	No	Other	Other	###	5	mild	mild	JJ	JJ	_	6	amod	_	_
asthma	NN	I-NP	O	Other	No	No	Other	Other	###	6	asthma	asthma	NN	NN	_	3	nmod	_	_
who	WP	B-NP	O	Other	No	No	Other	Other	###	7	who	who	WP	WP	_	10	nsubjpass	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	8	were	were	VBD	VBD	_	10	auxpass	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	9	not	not	RB	RB	_	10	neg	_	_
treated	VBN	I-VP	O	Other	No	No	Other	Other	###	10	treated	treated	VBN	VBN	_	3	acl:relcl	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	11	with	with	IN	IN	_	13	case	_	_
inhaled	VBN	B-NP	O	Other	No	No	Other	Other	###	12	inhaled	inhaled	VBN	VBN	_	13	amod	_	_
corticosteroids	NNS	I-NP	O	Other	No	No	Other	Other	###	13	corticosteroids	corticosteroids	NNS	NNS	_	10	nmod	_	_
who	WP	B-NP	O	Other	No	No	Other	Other	###	14	who	who	WP	WP	_	17	nsubjpass	_	_
had	VBD	B-VP	O	Other	No	No	Other	Other	###	15	had	had	VBD	VBD	_	17	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	16	been	been	VBN	VBN	_	17	auxpass	_	_
included	VBN	I-VP	O	Other	No	No	Other	Other	###	17	included	included	VBN	VBN	_	13	acl:relcl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	18	in	in	IN	IN	_	29	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	19	a	a	DT	DT	_	29	det	_	_
previously	RB	I-NP	O	Other	No	No	Other	Other	###	20	previously	previously	RB	RB	_	21	advmod	_	_
reported	VBN	I-NP	O	Other	No	No	Other	Other	###	21	reported	reported	VBN	VBN	_	29	amod	_	_
double-blind	JJ	I-NP	O	Other	No	No	Other	Other	###	22	double-blind	double-blind	JJ	JJ	_	29	amod	_	_
,	,	I-NP	O	Other	No	No	Other	Other	###	23	,	,	,	,	_	22	punct	_	_
placebo	JJ	I-NP	O	Other	No	No	Other	Other	###	24	placebo	placebo	JJ	JJ	_	22	dep	_	_
-	-	O	O	Other	No	No	Other	Other	###	25	-	-	-	-	_	22	punct	_	_
controlled	JJ	I-NP	O	Other	No	No	Other	Other	###	26	controlled	controlled	JJ	JJ	_	22	dep	_	_
,	,	I-NP	O	Other	No	No	Other	Other	###	27	,	,	,	,	_	22	punct	_	_
crossover	JJ	I-NP	O	Other	No	No	Other	Other	###	28	crossover	crossover	JJ	JJ	_	22	dep	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	29	study	study	NN	NN	_	17	nmod	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	30	with	with	IN	IN	_	31	case	_	_
FP	NN	B-NP	O	Other	No	No	Other	Other	###	31	FP	FP	NN	NN	_	29	nmod	_	_
[	(	O	O	Other	No	No	Other	Other	###	32	[	[	(	(	_	29	acl	_	_
34	CD	B-NP	O	Other	No	No	Other	Other	###	33	34	34	CD	CD	_	32	nummod	_	_
]	)	O	O	Other	No	No	Other	Other	###	34	]	]	)	)	_	32	xcomp	_	_
.	.	O	O	Other	No	No	Other	Other	###	35	.	.	.	.	_	2	punct	_	_

Seven	CD	B-NP	O	Other	No	No	Other	Other	###	1	Seven	Seven	CD	CD	_	2	nummod	_	_
patients	NNS	I-NP	O	Other	No	No	Other	Other	###	2	patients	patients	NNS	NNS	_	6	nsubj	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	3	with	with	IN	IN	_	5	case	_	_
mild	JJ	B-NP	O	Other	No	No	Other	Other	###	4	mild	mild	JJ	JJ	_	5	amod	_	_
asthma	NN	I-NP	O	Other	No	No	Other	Other	###	5	asthma	asthma	NN	NN	_	2	nmod	_	_
entered	VBD	B-VP	O	Other	No	No	Other	Other	###	6	entered	entered	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	8	study	study	NN	NN	_	6	dobj	_	_
and	CC	O	O	Other	No	No	Other	Other	###	9	and	and	CC	CC	_	6	cc	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	10	were	were	VBD	VBD	_	11	auxpass	_	_
randomized	VBN	I-VP	O	Other	No	No	Other	Other	###	11	randomized	randomized	VBN	VBN	_	6	conj	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	12	to	to	TO	TO	_	13	mark	_	_
receive	VB	I-VP	O	Other	No	No	Other	Other	###	13	receive	receive	VB	VB	_	11	xcomp	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	14	a	a	DT	DT	_	16	det	_	_
single	JJ	I-NP	O	Other	No	No	Other	Other	###	15	single	single	JJ	JJ	_	16	amod	_	_
inhalation	NN	I-NP	O	Other	No	No	Other	Other	###	16	inhalation	inhalation	NN	NN	_	13	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	17	of	of	IN	IN	_	18	case	_	_
FP	NN	B-NP	O	Other	No	No	Other	Other	###	18	FP	FP	NN	NN	_	16	nmod	_	_
(	(	O	O	Other	No	No	Other	Other	###	19	(	(	(	(	_	23	punct	_	_
100	CD	B-NP	O	Other	No	No	Other	Other	###	20	100	100	CD	CD	_	23	nummod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	21	and	and	CC	CC	_	20	cc	_	_
500	CD	I-NP	O	Other	No	No	Other	Other	###	22	500	500	CD	CD	_	20	conj	_	_
microg	NN	I-NP	O	Other	No	No	Other	Other	###	23	microg	microg	NN	NN	_	16	appos	_	_
)	)	O	O	Other	No	No	Other	Other	###	24	)	)	)	)	_	23	punct	_	_
or	CC	O	O	Other	No	No	Other	Other	###	25	or	or	CC	CC	_	16	cc	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	26	a	a	DT	DT	_	29	det	_	_
matched	JJ	I-NP	O	Other	No	No	Other	Other	###	27	matched	matched	JJ	JJ	_	29	amod	_	_
placebo	NN	I-NP	O	Other	No	No	Other	Other	###	28	placebo	placebo	NN	NN	_	29	compound	_	_
control	NN	I-NP	O	Other	No	No	Other	Other	###	29	control	control	NN	NN	_	16	conj	_	_
via	IN	B-PP	O	Other	No	No	Other	Other	###	30	via	via	IN	IN	_	33	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	31	a	a	DT	DT	_	33	det	_	_
spacer	NN	I-NP	O	Other	No	No	Other	Other	###	32	spacer	spacer	NN	NN	_	33	compound	_	_
chamber	NN	I-NP	O	Other	No	No	Other	Other	###	33	chamber	chamber	NN	NN	_	29	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	34	,	,	,	,	_	6	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	35	and	and	CC	CC	_	6	cc	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	36	the	the	DT	DT	_	38	det	_	_
other	JJ	I-NP	O	Other	No	No	Other	Other	###	37	other	other	JJ	JJ	_	38	amod	_	_
treatment	NN	I-NP	O	Other	No	No	Other	Other	###	38	treatment	treatment	NN	NN	_	40	nsubjpass	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	39	was	was	VBD	VBD	_	40	auxpass	_	_
given	VBN	I-VP	O	Other	No	No	Other	Other	###	40	given	given	VBN	VBN	_	6	conj	_	_
after	IN	B-PP	O	Other	No	No	Other	Other	###	41	after	after	IN	IN	_	44	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	42	a	a	DT	DT	_	44	det	_	_
wash-out	JJ	I-NP	O	Other	No	No	Other	Other	###	43	wash-out	wash-out	JJ	JJ	_	44	amod	_	_
period	NN	I-NP	O	Other	No	No	Other	Other	###	44	period	period	NN	NN	_	40	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	45	of	of	IN	IN	_	51	case	_	_
at	IN	B-NP	O	Other	No	No	Other	Other	###	46	at	at	IN	IN	_	47	case	_	_
least	JJS	I-NP	O	Other	No	No	Other	Other	###	47	least	least	JJS	JJS	_	48	nmod:npmod	_	_
6	CD	I-NP	O	Other	No	No	Other	Other	###	48	6	6	CD	CD	_	51	nummod	_	_
d	NN	I-NP	O	Other	No	No	Other	Other	###	49	d	d	NN	NN	_	51	compound	_	_
.	.	O	O	Other	No	No	Other	Other	###	50	.	.	.	.	_	51	punct	_	_
Blood	NN	I-NP	O	Other	No	No	Other	Other	###	51	Blood	Blood	NN	NN	_	44	nmod	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	52	was	was	VBD	VBD	_	53	auxpass	_	_
taken	VBN	I-VP	O	Other	No	No	Other	Other	###	53	taken	taken	VBN	VBN	_	40	conj	_	_
for	IN	B-PP	O	Other	No	No	Other	Other	###	54	for	for	IN	IN	_	55	case	_	_
preparation	NN	B-NP	O	Other	No	No	Other	Other	###	55	preparation	preparation	NN	NN	_	53	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	56	of	of	IN	IN	_	57	case	_	_
PBMCs	NNS	B-NP	B-cell_type	Other	No	No	Other	Other	###	57	PBMCs	PBMCs	NNS	NNS	_	55	nmod	_	_
at	IN	B-PP	O	Other	No	No	Other	Other	###	58	at	at	IN	IN	_	62	case	_	_
1	CD	B-NP	O	Other	No	No	Other	Other	###	59	1	1	CD	CD	_	62	nummod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	60	and	and	CC	CC	_	59	cc	_	_
2	CD	I-NP	O	Other	No	No	Other	Other	###	61	2	2	CD	CD	_	59	conj	_	_
h	NN	I-NP	O	Other	No	No	Other	Other	###	62	h	h	NN	NN	_	55	nmod	_	_
after	IN	B-PP	O	Other	No	No	Other	Other	###	63	after	after	IN	IN	_	65	case	_	_
drug	NN	B-NP	O	Other	No	No	Other	Other	###	64	drug	drug	NN	NN	_	65	compound	_	_
administration	NN	I-NP	O	Other	No	No	Other	Other	###	65	administration	administration	NN	NN	_	62	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	66	.	.	.	.	_	6	punct	_	_

All	DT	B-NP	O	Other	No	No	Other	Other	###	1	All	All	DT	DT	_	2	det	_	_
patients	NNS	I-NP	O	Other	No	No	Other	Other	###	2	patients	patients	NNS	NNS	_	3	nsubj	_	_
gave	VBD	B-VP	O	Other	No	No	Other	Other	###	3	gave	gave	VBD	VBD	_	0	root	_	_
informed	VBN	B-NP	O	Other	No	No	Other	Other	###	4	informed	informed	VBN	VBN	_	5	amod	_	_
consent	NN	I-NP	O	Other	No	No	Other	Other	###	5	consent	consent	NN	NN	_	3	dobj	_	_
and	CC	O	O	Other	No	No	Other	Other	###	6	and	and	CC	CC	_	3	cc	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	8	study	study	NN	NN	_	10	nsubjpass	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	9	was	was	VBD	VBD	_	10	auxpass	_	_
approved	VBN	I-VP	O	Other	No	No	Other	Other	###	10	approved	approved	VBN	VBN	_	3	conj	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	11	by	by	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	12	the	the	DT	DT	_	14	det	_	_
Ethics	NNP	I-NP	O	Other	No	No	Other	Other	###	13	Ethics	Ethics	NNP	NNP	_	14	compound	_	_
Committee	NNP	I-NP	O	Other	No	No	Other	Other	###	14	Committee	Committee	NNP	NNP	_	10	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	15	of	of	IN	IN	_	18	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	16	the	the	DT	DT	_	18	det	_	_
Royal	NNP	I-NP	O	Other	No	No	Other	Other	###	17	Royal	Royal	NNP	NNP	_	18	compound	_	_
Brompton	NNP	I-NP	O	Other	No	No	Other	Other	###	18	Brompton	Brompton	NNP	NNP	_	14	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	19	and	and	CC	CC	_	18	cc	_	_
Harefield	NNP	B-NP	O	Other	No	No	Other	Other	###	20	Harefield	Harefield	NNP	NNP	_	23	compound	_	_
Hospitals	NNP	I-NP	O	Other	No	No	Other	Other	###	21	Hospitals	Hospitals	NNP	NNP	_	23	compound	_	_
NHS	NNP	I-NP	O	Other	No	No	Other	Other	###	22	NHS	NHS	NNP	NNP	_	23	compound	_	_
Trust	NNP	I-NP	O	Other	No	No	Other	Other	###	23	Trust	Trust	NNP	NNP	_	18	conj	_	_
.	.	O	O	Other	No	No	Other	Other	###	24	.	.	.	.	_	3	punct	_	_

The	DT	B-NP	O	Other	No	No	Other	Other	###	1	The	The	DT	DT	_	3	det	_	_
clinical	JJ	I-NP	O	Other	No	No	Other	Other	###	2	clinical	clinical	JJ	JJ	_	3	amod	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	3	study	study	NN	NN	_	5	nsubjpass	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	4	was	was	VBD	VBD	_	5	auxpass	_	_
conducted	VBN	I-VP	O	Other	No	No	Other	Other	###	5	conducted	conducted	VBN	VBN	_	0	root	_	_
before	IN	B-PP	O	Other	No	No	Other	Other	###	6	before	before	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
requirement	NN	I-NP	O	Other	No	No	Other	Other	###	8	requirement	requirement	NN	NN	_	5	nmod	_	_
for	IN	B-PP	O	Other	No	No	Other	Other	###	9	for	for	IN	IN	_	12	case	_	_
Clinical	NNP	B-NP	O	Other	No	No	Other	Other	###	10	Clinical	Clinical	NNP	NNP	_	12	amod	_	_
Trial	NNP	I-NP	O	Other	No	No	Other	Other	###	11	Trial	Trial	NNP	NNP	_	12	compound	_	_
Registration	NNP	I-NP	O	Other	No	No	Other	Other	###	12	Registration	Registration	NNP	NNP	_	8	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	13	.	.	.	.	_	5	punct	_	_

